Risk of Ischemic Stroke in Asymptomatic Atrial Fibrillation Incidentally Detected in Primary Care Compared with Other Clinical Presentations

被引:40
|
作者
Wallenhorst, Christopher [1 ]
Martinez, Carlos [1 ]
Freedman, Ben [2 ,3 ,4 ]
机构
[1] Inst Epidemiol Stat & Informat GmbH, Dinkelfeld 32, D-60388 Frankfurt, Germany
[2] Univ Sydney, Charles Perkins Ctr, Heart Res Inst, Sydney, NSW, Australia
[3] Concord Hosp, Dept Cardiol, Sydney, NSW, Australia
[4] Concord Hosp, ANZAC Res Inst, Sydney, NSW, Australia
关键词
atrial fibrillation; ischemic stroke; stroke prevention; anticoagulation; MANAGEMENT; GUIDELINES; PROGNOSIS;
D O I
10.1055/a-1541-3885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is uncertain whether stroke risk of asymptomatic ambulatory atrial fibrillation (AA-AF) incidentally detected in primary care is comparable with other clinical AF presentations in primary care or hospital. Methods The stoke risk of 22,035 patients with incident nonvalvular AF from the United Kingdom primary care Clinical Practice Research Datalink with linkage to hospitalization and mortality data was compared with 23,605 controls without AF (age- and sex-matched 5:1 to 5,409 AA-AF patients). Incident AF included 5,913 with symptomatic ambulatory AF (SA-AF); 4,989 with primary and 5,724 with nonprimary hospital AF discharge diagnosis (PH-AF and non-PH-AF); and 5,409 with AA-AF. Ischemic stroke adjusted subhazard ratios (aSHRs) within 3 years of AA-AF were compared with SA-AF, PH-AF, non-PH-AF, and no AF, accounting for mortality as competing risk and adjusted for ischemic stroke risk factors. Results There were 1,026 ischemic strokes in 49,544 person-years in patients with incident AF (crude incidence rate: 2.1 ischemic strokes/100 person-years). Ischemic stroke aSHR over 3 years showed no differences between AA-AF and SA-AF, PH-AF, and non-PH-AF groups (aSHR: 0.87-1.01 vs. AA-AF). All AF groups showed a significantly higher aSHR compared with no AF. Conclusion Ischemic stroke risk in patients with AA-AF incidentally detected in primary care is far from benign, and not less than incident AF presenting clinically in general practice or hospital. This provides justification for identification of previously undetected AF, e.g., by opportunistic screening, and subsequent stroke prevention with thromboprophylaxis, to reduce the approximately 10% of ischemic strokes related to unrecognized AF.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [1] Atrial Fibrillation Detected by Single Time-Point Handheld Electrocardiogram Screening and the Risk of Ischemic Stroke
    Sun, Wen
    Freedman, Ben
    Martinez, Carlos
    Wallenhorst, Christopher
    Yan, Bryan P.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (02) : 286 - 294
  • [2] Asymptomatic atrial fibrillation and risk of stroke
    Stachon, P.
    Ahrens, I.
    Faber, T.
    Bode, C.
    Zirlik, A.
    PANMINERVA MEDICA, 2015, 57 (04) : 211 - 215
  • [3] Atrial Fibrillation and Ischemic Stroke: A Clinical Review
    Migdady, Ibrahim
    Russman, Andrew
    Buletko, Andrew B.
    SEMINARS IN NEUROLOGY, 2021, 41 (04) : 348 - 364
  • [4] Asymptomatic Atrial Fibrillation After Cryptogenetic Stroke Incidence, Clinical Significance, and Therapeutic Implications
    Raviele, Antonio
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (02): : 249 - 251
  • [5] Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death
    Yang, Xiao-Meng
    Rao, Zhen-Zhen
    Gu, Hong-Qiu
    Zhao, Xing-Quan
    Wang, Chun-Juan
    Liu, Li-Ping
    Liu, Chelsea
    Wang, Yi-Long
    Li, Zi-Xiao
    Xiao, Rui-Ping
    Wang, Yong-Jun
    STROKE, 2019, 50 (05) : 1124 - 1129
  • [6] Atrial fibrillation risk factors in patients with ischemic stroke
    Wankowicz, Pawel
    Nowacki, Przemyslaw
    Golab-Janowska, Monika
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (01) : 19 - 24
  • [7] Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
    Lai, Kuan-Cheng
    Chen, Sy-Jou
    Lin, Chin-Sheng
    Yang, Fu-Chi
    Lin, Cheng-Li
    Hsu, Chin-Wang
    Huang, Wen-Chen
    Kao, Chia-Hung
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [8] A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score
    Singer, Daniel E.
    Chang, Yuchiao
    Borowsky, Leila H.
    Fang, Margaret C.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Reynolds, Kristi
    Go, Alan S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (03):
  • [9] Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach
    Paquet, Maryse
    Cerasuolo, Joshua O.
    Thorburn, Victoria
    Fridman, Sebastian
    Alsubaie, Rasha
    Lopes, Renato D.
    Cipriano, Lauren E.
    Salamone, Paula
    Melling, C. W. James
    Khan, Ali R.
    Sedeno, Lucas
    Fang, Jiming
    Drangova, Maria
    Montero-Odasso, Manuel
    Mandzia, Jennifer
    Khaw, Alexander V.
    Racosta, Juan M.
    Paturel, Justin
    Samoilov, Lucy
    Stirling, Devin
    Balint, Brittany
    Jaremek, Victoria
    Koschinsky, Marlys L.
    Boffa, Michael B.
    Summers, Kelly
    Ibanez, Agustin
    Mrkobrada, Marko
    Saposnik, Gustavo
    Kimpinski, Kurt
    Whitehead, Shawn N.
    Sposato, Luciano A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (03): : 606 - 619
  • [10] Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening
    Gibbs, Harry
    Freedman, Ben
    Rosenqvist, Marten
    Virdone, Saverio
    Al Mahmeed, Wael
    Ambrosio, Giuseppe
    Camm, A. John
    Jacobson, Barry
    Jerjes-Sanchez, Carlos
    Kayani, Gloria
    Oto, Ali
    Panchenko, Elizaveta
    Ragy, Hany
    Kakkar, Ajay K.
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (07): : 893 - +